Prelude Capital Management’s Alpine Immune Sciences Inc ALPN Stock Holding History

Prelude Capital Management’s Portfolio ALPN Stock Details ALPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-27,100	Closed	-$1.07M	–	1577
2024 Q1	$1.07M	Sell	27,100 -14,400	-35%	-$425K	0.06%	379
2023 Q4	$791K	Buy	+41,500	New	+$577K	0.05%	362
2015 Q4	–	Sell	-75	Closed	-$4K	–	1737
2015 Q3	$4K	Buy	+75	New	+$4.93K	﹤0.01%	1409

Prelude Capital Management's ALPN Position: Q2 2024 in Review

Prelude Capital Management sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 27,100 shares — an estimated $1.07M sold.

Prelude Capital Management first reported a position in ALPN in Q3 2015 and held it in 3 quarters. The position peaked at $1.07M in Q1 2024. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

Prelude Capital Management reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
Prelude Capital Management sold 27,100 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $1.07M.
Prelude Capital Management first reported a position in Alpine Immune Sciences Inc in Q3 2015 and held it in 3 quarters.
Prelude Capital Management's Alpine Immune Sciences Inc position peaked at $1.07M in Q1 2024.
0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on Prelude Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.